date:May 07, 2013
e (NEI) of the National Institutes of Health (NIH). This study follows AREDS1, which was published in 2001 and found that people at high risk of developing advanced stages of AMD lowered their risk by 25 30 percent when treated with a high-dose combination of vitamin C, vitamin E, beta-carotene, zinc and copper. AREDS2 assessed the effects of oral supplementation of certain eye nutrients in more than 4,000 participants ranging from 50-85 years of age, most of whom at the time of enrollment had